Reducing overdiagnosis by polygenic risk-stratified screening: findings from the Finnish section of the ERSPC




Pashayan N, Pharoah PDP, Schleutker J, Talala K, Tammela TLJ, Maattanen L, Harrington P, Tyrer J, Eeles R, Duffy SW, Auvinen A

PublisherNATURE PUBLISHING GROUP

2015

British Journal of Cancer

BRITISH JOURNAL OF CANCER

BRIT J CANCER

113

7

1086

1093

8

0007-0920

DOIhttps://doi.org/10.1038/bjc.2015.289



Conclusion: Targeting screening to men at higher polygenic risk could reduce the proportion of cancers overdiagnosed.




Last updated on 2024-26-11 at 18:11